Takeda (TAK) stock is in focus as the company targets ¥200B+ annual savings by FY2028 via restructuring and business ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best healthcare stocks to buy for 2026. Takeda Pharmaceutical Company Limited (NYSE:TAK) reported Q3 FY2025 results on January 29, 2026, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results